ESMO-话题@MedSci

#ESMO#

215篇内容 | 6354人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1280977, encodeId=c18812809e7ae, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2019 ESMO临床实践指南：肾细胞癌的诊断，治疗和随访, objectType=article, longId=161740, objectId=0907161e404f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0907161e404f, replyNumber=0, likeNumber=30, createdTime=2019-03-07, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0907161e404f, moduleTitle=2019 ESMO临床实践指南：肾细胞癌的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0907161e404f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280976, encodeId=8b2d12809e69c, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=J Biomed Sci：L-caldesmon改变RANKL诱导的破骨细胞中的细胞扩散和粘附力, objectType=article, longId=159490, objectId=6d4b159490e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d4b159490e2, replyNumber=0, likeNumber=71, createdTime=2019-02-05, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d4b159490e2, moduleTitle=J Biomed Sci：L-caldesmon改变RANKL诱导的破骨细胞中的细胞扩散和粘附力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d4b159490e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280975, encodeId=722412809e5be, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=百济神州在ESMO-IO上公布替雷利珠单抗1A/1B期临床研究更新数据, objectType=article, longId=155939, objectId=0bba15593905, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bba15593905, replyNumber=0, likeNumber=99, createdTime=2018-12-18, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bba15593905, moduleTitle=百济神州在ESMO-IO上公布替雷利珠单抗1A/1B期临床研究更新数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bba15593905)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280974, encodeId=996e12809e40f, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=【2018 ESMO】探寻AURA3研究奥希替尼耐药机制，精准克服耐药, objectType=article, longId=154862, objectId=ba8f1548626f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba8f1548626f, replyNumber=0, likeNumber=91, createdTime=2018-12-02, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba8f1548626f, moduleTitle=【2018 ESMO】探寻AURA3研究奥希替尼耐药机制，精准克服耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba8f1548626f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280973, encodeId=be4b12809e355, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=【2018 ESMO ASIA】SOLO1研究：BRCA突变卵巢癌患者一线维持治疗结果喜人, objectType=article, longId=154850, objectId=6a581548506d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a581548506d, replyNumber=0, likeNumber=87, createdTime=2018-12-02, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a581548506d, moduleTitle=【2018 ESMO ASIA】SOLO1研究：BRCA突变卵巢癌患者一线维持治疗结果喜人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a581548506d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280972, encodeId=c24c12809e2e9, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=【2018 ESMO】KEYNOTE-057研究：卡介苗治疗无效的高风险非肌层浸润性膀胱癌，帕博利珠单抗显疗效, objectType=article, longId=152388, objectId=65e815238817, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65e815238817, replyNumber=0, likeNumber=74, createdTime=2018-11-01, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65e815238817, moduleTitle=【2018 ESMO】KEYNOTE-057研究：卡介苗治疗无效的高风险非肌层浸润性膀胱癌，帕博利珠单抗显疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65e815238817)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280971, encodeId=0bc812809e107, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=【2018 ESMO】周彩存教授谈KEYNOTE-010三年随访数据及免疫治疗趋势, objectType=article, longId=152293, objectId=bb8d15229332, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb8d15229332, replyNumber=0, likeNumber=69, createdTime=2018-10-31, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb8d15229332, moduleTitle=【2018 ESMO】周彩存教授谈KEYNOTE-010三年随访数据及免疫治疗趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb8d15229332)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280970, encodeId=6c8c12809e0d1, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=【2018 ESMO】沈琳教授团队专访：突破神经内分泌肿瘤疗效瓶颈，免疫治疗任重而道远, objectType=article, longId=152267, objectId=aa1f15226e09, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa1f15226e09, replyNumber=0, likeNumber=103, createdTime=2018-10-31, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa1f15226e09, moduleTitle=【2018 ESMO】沈琳教授团队专访：突破神经内分泌肿瘤疗效瓶颈，免疫治疗任重而道远, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa1f15226e09)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280969, encodeId=6f161280969e9, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=【2018 ESMO】立足实践，Nivolumab真实世界研究与临床试验结果遥相呼应, objectType=article, longId=152203, objectId=9b9e15220396, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b9e15220396, replyNumber=0, likeNumber=66, createdTime=2018-10-31, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b9e15220396, moduleTitle=【2018 ESMO】立足实践，Nivolumab真实世界研究与临床试验结果遥相呼应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b9e15220396)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280968, encodeId=05e412809684b, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO临床实践指南：肝细胞癌的诊断，治疗和随访, objectType=article, longId=150850, objectId=5d7215085029, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d7215085029, replyNumber=0, likeNumber=58, createdTime=2018-10-13, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d7215085029, moduleTitle=2018 ESMO临床实践指南：肝细胞癌的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d7215085029)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280967, encodeId=b45f128096ef3, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO/EURACAN临床实践指南：骨肉瘤的诊断，治疗和随访, objectType=article, longId=150759, objectId=f0f4150e5974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0f4150e5974, replyNumber=0, likeNumber=38, createdTime=2018-10-12, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0f4150e5974, moduleTitle=2018 ESMO/EURACAN临床实践指南：骨肉瘤的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0f4150e5974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280966, encodeId=6dda1280966b9, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO临床实践指南：转移性非小细胞肺癌的诊断，治疗和随访, objectType=article, longId=150607, objectId=96e915060e0f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96e915060e0f, replyNumber=0, likeNumber=31, createdTime=2018-10-10, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96e915060e0f, moduleTitle=2018 ESMO临床实践指南：转移性非小细胞肺癌的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96e915060e0f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280965, encodeId=fa45128096513, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2016 ESMO共识会议指南：睾丸生殖细胞癌的诊断，治疗和随访, objectType=article, longId=146951, objectId=57eb146951b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=57eb146951b4, replyNumber=0, likeNumber=35, createdTime=2018-08-20, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=57eb146951b4, moduleTitle=2016 ESMO共识会议指南：睾丸生殖细胞癌的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57eb146951b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280964, encodeId=c5fd1280964cf, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=ESO-ESMO晚期乳腺癌国际共识指南更新了！看看不同类型乳腺癌怎么治？, objectType=article, longId=145577, objectId=0f461455e705, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f461455e705, replyNumber=0, likeNumber=61, createdTime=2018-08-02, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f461455e705, moduleTitle=ESO-ESMO晚期乳腺癌国际共识指南更新了！看看不同类型乳腺癌怎么治？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f461455e705)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280963, encodeId=d741128096307, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO临床实践指南：成人癌痛的管理, objectType=article, longId=145423, objectId=31a01454230c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31a01454230c, replyNumber=0, likeNumber=28, createdTime=2018-07-30, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31a01454230c, moduleTitle=2018 ESMO临床实践指南：成人癌痛的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31a01454230c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280962, encodeId=5467128096232, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO临床实践指南：成人癌症患者谵妄的管理, objectType=article, longId=144513, objectId=a0331445138a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0331445138a, replyNumber=0, likeNumber=0, createdTime=2018-07-17, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0331445138a, moduleTitle=2018 ESMO临床实践指南：成人癌症患者谵妄的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0331445138a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280961, encodeId=937d1280961f8, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO临床实践指南：华氏巨球蛋白血症的诊断，治疗和随访, objectType=article, longId=144298, objectId=9388144298e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9388144298e2, replyNumber=0, likeNumber=37, createdTime=2018-07-14, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9388144298e2, moduleTitle=2018 ESMO临床实践指南：华氏巨球蛋白血症的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9388144298e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280960, encodeId=6ed2128096056, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO临床实践指南：癌症患者腹泻, objectType=article, longId=141825, objectId=876d14182537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=876d14182537, replyNumber=0, likeNumber=27, createdTime=2018-06-29, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=876d14182537, moduleTitle=2018 ESMO临床实践指南：癌症患者腹泻, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=876d14182537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280959, encodeId=6c39128095939, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO临床实践指南：原发性皮肤淋巴瘤的诊断、治疗与随访, objectType=article, longId=140759, objectId=8815140e593e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8815140e593e, replyNumber=0, likeNumber=25, createdTime=2018-06-15, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8815140e593e, moduleTitle=2018 ESMO临床实践指南：原发性皮肤淋巴瘤的诊断、治疗与随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8815140e593e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1280958, encodeId=72c5128095817, content=<a href='/topic/show?id=50d6e0215a' target=_blank style='color:#2F92EE;'>#ESMO#</a>, objectTitle=2018 ESMO/EURACAN临床实践指南：胃肠道间质瘤的诊断，治疗和随访, objectType=article, longId=139961, objectId=859f139961b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=859f139961b8, replyNumber=0, likeNumber=29, createdTime=2018-06-06, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=859f139961b8, moduleTitle=2018 ESMO/EURACAN临床实践指南：胃肠道间质瘤的诊断，治疗和随访, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=859f139961b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ESMO

2020-05-29

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2019 ESMO临床实践指南：肾细胞癌的诊断，治疗和随访

2019-03-07

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

J Biomed Sci：L-caldesmon改变RANKL诱导的破骨细胞中的细胞扩散和粘附力

2019-02-05

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

百济神州在ESMO-IO上公布替雷利珠单抗1A/1B期临床研究更新数据

2018-12-18

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

【2018 ESMO】探寻AURA3研究奥希替尼耐药机制，精准克服耐药

2018-12-02

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

【2018 ESMO ASIA】SOLO1研究：BRCA突变卵巢癌患者一线维持治疗结果喜人

2018-12-02

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

【2018 ESMO】KEYNOTE-057研究：卡介苗治疗无效的高风险非肌层浸润性膀胱癌，帕博利珠单抗显疗效

2018-11-01

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

【2018 ESMO】周彩存教授谈KEYNOTE-010三年随访数据及免疫治疗趋势

2018-10-31

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

【2018 ESMO】沈琳教授团队专访：突破神经内分泌肿瘤疗效瓶颈，免疫治疗任重而道远

2018-10-31

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

【2018 ESMO】立足实践，Nivolumab真实世界研究与临床试验结果遥相呼应

2018-10-31

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO临床实践指南：肝细胞癌的诊断，治疗和随访

2018-10-13

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO/EURACAN临床实践指南：骨肉瘤的诊断，治疗和随访

2018-10-12

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO临床实践指南：转移性非小细胞肺癌的诊断，治疗和随访

2018-10-10

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2016 ESMO共识会议指南：睾丸生殖细胞癌的诊断，治疗和随访

2018-08-20

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

ESO-ESMO晚期乳腺癌国际共识指南更新了！看看不同类型乳腺癌怎么治？

2018-08-02

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO临床实践指南：成人癌痛的管理

2018-07-30

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO临床实践指南：成人癌症患者谵妄的管理

2018-07-17

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO临床实践指南：华氏巨球蛋白血症的诊断，治疗和随访

2018-07-14

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO临床实践指南：癌症患者腹泻

2018-06-29

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO临床实践指南：原发性皮肤淋巴瘤的诊断、治疗与随访

2018-06-15

zhang92560 (审核中...)

前往app查看评论内容

#ESMO#

2018 ESMO/EURACAN临床实践指南：胃肠道间质瘤的诊断，治疗和随访

2018-06-06

科室
- - 订阅+
  - 更多科室
工具
服务